AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
KRON(Quitar la ciudad)
Kronos Bio·NASDAQ
--
--(--)
Kronos Bio (KRON) Financial Statements
Kronos Bio (KRON) Cash Flow Statement
During Q1 2024, Kronos Bio (KRON) generated -23.90M in cash flow from operating activities, 5.77M from investing activities, and 0 from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q1,2024 | TTM |
|---|
Start Date | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2024 | -- |
End Date | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -7.07M -- | -19.00M -168.86% | -23.48M -23.61% | -5.95M +74.68% | -23.90M -301.87% | -- -- |
Depreciation and Amortization | 160.00K -- | 444.00K +177.50% | 557.00K +25.45% | 569.00K +2.15% | 475.00K -16.52% | -- -- |
Change in Working Capital | -707.00K -- | -189.00K +73.27% | 3.34M +1865.61% | 13.69M +310.13% | -7.80M -156.96% | -- -- |
Net Cash Flows from Investing Activities | 5.31M -- | -88.15M -1760.06% | -26.34M +70.12% | -6.36M +75.87% | 5.77M +190.79% | -- -- |
Purchase of PPE and Intangible Assets | 626.00K -- | 1.50M +140.42% | 366.00K -75.68% | 126.00K -65.57% | 7.00K -94.44% | -- -- |
Increase in Investments | 2.31M -- | 126.06M +5359.51% | 94.54M -25.00% | 102.59M +8.52% | 48.75M -52.48% | -- -- |
Net Cash Flows from Financing Activities | 12.00K -- | 585.00K +4775.00% | 529.00K -9.57% | 0 -100.00% | 0 -- | -- -- |
Change in Capital Stock | 20.00K -- | 590.00K +2850.00% | 529.00K -10.34% | -- -- | -- -- | -- -- |
Increase in Capital Stock | 20.00K -- | 590.00K +2850.00% | 529.00K -10.34% | -- -- | -- -- | -- -- |
Net Increase in Cash and Cash Equivalents | -1.74M -- | -106.56M -6010.21% | -49.29M +53.74% | -12.30M +75.04% | -18.13M -47.37% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 32.57M -- | 250.04M +667.69% | 200.30M -19.89% | 78.00M -61.06% | 64.33M -17.53% | -- -- |
Cash and Cash Equivalents at End of Period | 30.83M -- | 143.47M +365.43% | 151.00M +5.25% | 65.70M -56.49% | 46.20M -29.68% | -- -- |
You can ask Aime
No Data
